Hepatitis C Global Market Report 2024

Description

Hepatitis C is a viral infection that affects the liver, leading to inflammation and gradual destruction of liver tissues. The primary cause of hepatitis C is an infection with the hepatitis C virus (HCV), a virus transmitted through contaminated blood. The most common mode of transmission is through the sharing of needles or other equipment used for injecting drugs.

The main types of hepatitis C are chronic hepatitis C, acute hepatitis C, and others. Chronic hepatitis C denotes a persistent infection caused by the hepatitis C virus, occurring when the body is unable to effectively combat the virus. Treatment options for chronic hepatitis C include antiviral drugs, vaccines, immune modulator drugs, surgery, and others. The diagnostic process typically involves liver biopsy, blood tests, imaging tests, and others, with distribution through hospital and retail pharmacies, as well as online pharmacies. End-users encompass hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, research institutes, and home care settings.

The hepatitis C market research report is one of a series of new reports from The Business Research Company that provides hepatitis C market statistics, including hepatitis C industry global market size, regional shares, competitors with a hepatitis C market share, detailed hepatitis C market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis C industry. This hepatitis C market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hepatitis c market size has grown rapidly in recent years. It will grow from $59.58 billion in 2023 to $68.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth observed in the historical period can be attributed to factors such as blood transfusion practices, injection drug use, limited treatment options, and the development of direct-acting antivirals (DAAs).

The hepatitis c market size is expected to see rapid growth in the next few years. It will grow to $117.94 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The anticipated growth in the forecast period can be attributed to global elimination efforts, improved testing and screening practices, increasing healthcare spending, the integration of telemedicine, and the emergence of therapeutic combinations. Notable trends expected in the forecast period include a focus on accessible and affordable treatment options, targeted efforts for high-risk groups, advancements in drug formulations, collaborative initiatives and partnerships, as well as the integration of telehealth and digital solutions in hepatitis C management.

The hepatitis C market is anticipated to experience growth driven by an increase in viral infections. Viral infections, caused by viruses within the body, are addressed by hepatitis C treatment, which aims to eradicate the viral infection and restore the immune response in patients. As reported by the European Centre for Disease Prevention and Control, 14,560 cases of hepatitis C were reported in 29 European Economic Area (EEA) member states in 2021, marking an increase from the previous year's 13,914 cases. This rise in viral infections serves as a significant factor propelling the hepatitis C market.

The prevalence of hepatitis is expected to contribute to the growth of the hepatitis C market. Hepatitis, an inflammatory liver condition commonly caused by viral infections, particularly hepatitis viruses A, B, C, D, and E, is a focus area for the Hepatitis C market. Data from the World Health Organization (WHO) in July 2021 revealed an estimated 58 million individuals with chronic hepatitis C virus infection, experiencing 1.5 million new infections annually. The increasing prevalence of hepatitis is a key driver for the growth of the hepatitis C market.

A noteworthy trend gaining popularity in the hepatitis C market is the advancement in diagnostic technologies. Major companies in the market are adopting new technologies to maintain their market positions. In July 2022, F. Hoffmann-La Roche Ltd. introduced the Elecsys HCV Duo immunoassay, allowing the independent and simultaneous determination of hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. The test aids in identifying patients recovering from or exhibiting symptoms of chronic infection, potentially leading to other diseases such as liver cancer.

Strategic alliances are a focal point for major companies operating in the hepatitis C market to strengthen their positions. In July 2021, Medecins Sans Frontieres (MSF), FIND, and Treatment Action Group joined forces to address disparities in access to diagnostics and treatment for the hepatitis C virus (HCV) in low- and middle-income countries (LMICs). The partnership emphasizes the significance of collaborative efforts to save lives, reduce costs in national budgets, and prove cost-effective.

In September 2022, Gilead Sciences Inc. partnered with Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center for Health Advancement in Vietnam (HAIVN). This public-private initiative aims to improve the management of viral hepatitis in Vietnam and the Philippines, aligning with the global goal of hepatitis C elimination by 2030. The collaboration involves institutions such as Brigham and Women's Hospital and Beth Israel Deaconess Medical Center in the U.S. and Harvard Medical School.

Major companies operating in the hepatitis c market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation , GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., LEO Pharma A/S, Biocon Limited, Kadmon Holdings Inc.

North America was the largest region in the hepatitis C market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hepatitis c market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The hepatitis C market consists of revenues earned by entities by providing shunt procedures, hepatic resection, and biopsies. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis C market also includes sales of ledipasvir and sofosbuvir, non-structural protein 5B (NS5B) polymerase inhibitors, non-structural protein 5A (NS5A) replication complex inhibitors, and elbasvir and grazoprevir drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis C Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis c market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis c ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis c market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types
2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments
3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffman La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14276

1. Executive Summary

2. Hepatitis C Market Characteristics

3. Hepatitis C Market Trends And Strategies

4. Hepatitis C Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Hepatitis C Market Size and Growth

5.1. Global Hepatitis C Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hepatitis C Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hepatitis C Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hepatitis C Market Segmentation

6.1. Global Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chronic Hepatitis C
Acute Hepatitis C
Other Types
6.2. Global Hepatitis C Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antiviral Drugs
Vaccine
Immune Modulator Drugs
Surgery
Other Treatments
6.3. Global Hepatitis C Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Liver Biopsy
Blood Tests
Imaging Tests
Other Diagnosis
6.4. Global Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital And Retail Pharmacies
Online Pharmacies
6.5. Global Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Laboratories
Research Institutes
Home Care Settings

7. Hepatitis C Market Regional And Country Analysis

7.1. Global Hepatitis C Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hepatitis C Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hepatitis C Market

8.1. Asia-Pacific Hepatitis C Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hepatitis C Market

9.1. China Hepatitis C Market Overview
9.2. China Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hepatitis C Market

10.1. India Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hepatitis C Market

11.1. Japan Hepatitis C Market Overview
11.2. Japan Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hepatitis C Market

12.1. Australia Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hepatitis C Market

13.1. Indonesia Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hepatitis C Market

14.1. South Korea Hepatitis C Market Overview
14.2. South Korea Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hepatitis C Market

15.1. Western Europe Hepatitis C Market Overview
15.2. Western Europe Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hepatitis C Market

16.1. UK Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hepatitis C Market

17.1. Germany Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hepatitis C Market

18.1. France Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hepatitis C Market

19.1. Italy Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hepatitis C Market

20.1. Spain Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hepatitis C Market

21.1. Eastern Europe Hepatitis C Market Overview
21.2. Eastern Europe Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hepatitis C Market

22.1. Russia Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hepatitis C Market

23.1. North America Hepatitis C Market Overview
23.2. North America Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hepatitis C Market

24.1. USA Hepatitis C Market Overview
24.2. USA Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hepatitis C Market

25.1. Canada Hepatitis C Market Overview
25.2. Canada Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hepatitis C Market

26.1. South America Hepatitis C Market Overview
26.2. South America Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hepatitis C Market

27.1. Brazil Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hepatitis C Market

28.1. Middle East Hepatitis C Market Overview
28.2. Middle East Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hepatitis C Market

29.1. Africa Hepatitis C Market Overview
29.2. Africa Hepatitis C Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hepatitis C Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hepatitis C Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hepatitis C Market Competitive Landscape And Company Profiles

30.1. Hepatitis C Market Competitive Landscape
30.2. Hepatitis C Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffman La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Hepatitis C Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Novartis AG
31.3. Bristol-Myers Squibb Company
31.4. Sumitomo Corporation
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Boehringer Ingelheim International GmbH.
31.9. Amgen Inc.
31.10. Toray Industries Inc.
31.11. Mylan N.V.
31.12. Teva Pharmaceutical Industries Ltd.
31.13. Astellas Pharma Inc.
31.14. Biogen Inc.
31.15. Vertex Pharmaceuticals Incorporated

32. Global Hepatitis C Market Competitive Benchmarking

33. Global Hepatitis C Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hepatitis C Market

35. Hepatitis C Market Future Outlook and Potential Analysis

35.1 Hepatitis C Market In 2028 - Countries Offering Most New Opportunities
35.2 Hepatitis C Market In 2028 - Segments Offering Most New Opportunities
35.3 Hepatitis C Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer